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The hexa-EF-hand Ca2+-binding protein calretinin (CR) is predominantly expressed
in specific neurons of the central and peripheral nervous system. However, CR expression
is also observed in non-neuronal cells, e.g., during embryonic development and in
mesothelioma cells. Of the 6 EF-hand domains, 5 are functional; the first 4 domains form
2 pairs showing high cooperativity within a pair that results in non-linear modulation of
intracellular Ca2+ signals by CR. EF-hand domain 5 has a low affinity and represents the
identified interaction site with CR-binding partners present in mouse cerebellar granule
cells. CR binding to other targets including the pore-forming α1 subunit of the Ca2+
channel CaV2.1, as well as to huntingtin indicates additional Ca2+ sensor functions
besides the well-known Ca2+-buffering functions. The absence of CR in cerebellar
granule cells of CR−/− mice results in increased excitability and altered firing of Purkinje
cells and promotes cerebellar 160-Hz oscillations impairing motor coordination. The
putative role of CR in neuroprotection is still highly discussed. Altogether, CR emerges
as a multi-functional protein also associated with development, i.e., cell proliferation,
differentiation, and cell death.
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BASIC FACTS ABOUT CALRETININ (CR)
Calretinin (CR; human gene symbol: CALB2), calbindin D-28k
(CB; CALB1) and secretagogin (SCGN; SCGN) represent the 3
members of the hexa-EF-hand protein family, also named the
calbindin sub-family [see recent reviews on CR (Camp et al.,
2009), CB (Schmidt, 2012) and SCGN (Alpar et al., 2012)]. They
all contain 6 structural motifs named EF-hand Ca2+-binding
domains. Each domain consists of an alpha-helix of approxi-
mately 10 amino acids, a Ca2+-chelating loop of 12 amino acids
and a second alpha-helix that is oriented perpendicular to the first
one (for more details on the EF-hand structure, see (Schwaller,
2010). CR (Mr 31 kDa) initially discovered in the retina, thus
the name: calcium+ retina = CR consists of 271 amino acids
in many species and is highly conserved; the number of amino
acids varies from 269 (e.g., Gallus gallus; Chicken) to 273 (e.g.,
Monodelphis domestica; Gray short-tailed opossum). CR is also
expressed in zebrafish (Danio rerio) and an invertebrate ortholog
named calbindin 53E (Cbp53E; previously calbindin-32) exists in
Drosophila melanogaster that shares the highest sequence iden-
tity with CR (Reifegerste et al., 1993). In CR, the first 5 EF-hand
domains are capable of binding Ca2+ ions, while the sixth one
is inactive (Stevens and Rogers, 1997; Schwaller et al., 1997).
Moreover the Ca2+-binding affinity for site 5 is very low (KD:
36μM) (Faas et al., 2007) indicating that this site is expected to
be rarely in the Ca2+-bound form in the cytoplasmic compart-
ment except in microdomains close to Ca2+ channels. The other
4 functional Ca2+-binding sites form 2 similar pairs likely con-
sisting of domains 1 and 2, as well as 3 and 4 showing strong
cooperativity within a pair (Faas et al., 2007). The apparent KD
(KD, app) for the 4 sites is 1.4–1.5μM with high cooperativity
(nH of 1.9; for more details on CR’s properties, see Table 1). This
property results in non-linear Ca2+ regulation in cells due to the
presence of CR. In a situation when the intracellular Ca2+ con-
centration [Ca2+]i is at resting (basal) levels of 50–100 nM, then
upon a brief and limited increase in [Ca2+]i, CR behaves like a
typical slow-onset buffer (EGTA). However, if the same increase
occurs at elevated [Ca2+]i, in the order of 1μM, when the first
site of a pair is in the Ca2+-bound form, cooperativity sets in
and CR functions almost like the fast buffer BAPTA (for more
details on this behavior, e.g., on the spatiotemporal patterns of
IP3-evoked Ca2+ signals, see Dargan et al. (2004) or on CR’s role
modeled for a train of intracellular Ca2+ signals, see Figure 3 in
(Schwaller, 2009). Thus, the Ca2+-binding kinetics of CR strongly
depends on [Ca2+]i levels at the time when another increase in
[Ca2+]i occurs. Besides these novel properties of Ca2+ binding
in a protein, first described for CR, several studies in the 90’s
reported CR to undergo considerable Ca2+-dependent conforma-
tional changes, which indicated that CR might also have “Ca2+
sensor” functions like the prototypical sensor calmodulin (CaM).
Results in support of CR acting as a Ca2+ sensor are presented in
Section III.
Up to date, no structural data of full-length CR have been
reported. However, the NMR structure of the N-terminal 100
amino acids of rat CR (Palczewska et al., 2001) embracing EF-
hand domains 1 and 2 are very similar to the NMR solution
structure of the corresponding domains in rat CB (Kojetin et al.,
2006). Together with the similar results from limited proteol-
ysis experiments obtained with CR and CB, this suggests that
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Table 1 | Properties of calretinin (modified from Schwaller, 2009, 2010, 2012).
General parameters Value (range) References/comments
Amino acids 269–273; 271 in most mammals; 310a Reifegerste et al., 1993; Zimmermann and Schwaller, 2002
Molecular mass (Mr ) 30–31 kDa Rogers, 1987
EF-hand domains 6 Rogers, 1987
Functional Ca2+-specific sites 5 Stevens and Rogers, 1997; Schwaller et al., 1997
Identified CR binding partners α1 subunit of CaV2.1, huntingtin Christel et al., 2012; Dong et al., 2012
METAL BINDING PROPERTIES AND MOBILITY
KD, Ca KD(T) 28 μM
KD(R) 68 nM
KD(app) 1.4 μM
EF5: 36 μMb
CR has 2 cooperative pairs (sites EF1-4) with indistinguishable bind-
ing properties. In the absence of Ca2+, the first site within a pair is in
the tensed (T) state and changes upon Ca2+ binding of the first site
within a pair to the relaxed (R) state. These results were obtained by
flash photolysis experiments Faas et al., 2007
KD, Mg 4.5 mM Stevens and Rogers, 1997
kon, Ca (μM−1s−1) Tensed (T) sites: 1.8
Relaxed (R) sites: 310
EF-hand domain 5: 7.3
Faas et al., 2007
Cooperativity Yes nH ≈ 1.3–1.9 Stevens and Rogers, 1997; Faas et al., 2007
Mobility DCabuffer (μm2s−1) in H2O
D10ms (μm2s−1)c
120 ± 1 (means ± s.e.m.)
3.2 (IQR 1.6–5.9)
Arendt et al., 2013
INTRACELLULAR CONCENTRATION IN
Frog saccular hair cells 1.2mM Edmonds et al., 2000
Rat outer hair cells 35μM Hackney et al., 2005
Rat inner hair cells 20μM Hackney et al., 2005
Mouse cerebellar granule cells 30–40μMd; 0.7–1.2mMe Gall et al., 2003
aDrosophila melanogaster calbindin 53E (previously calbindin-32) shows the highest sequence homology to calretinins of different species.
bA lower affinity for EF5 (KD: 0.5mM) was determined with the flow dialysis method (Schwaller et al., 1997).
cDiffusion determined in cerebellar granule cell dendrites by an anomalous subdiffusion model.
dBased on BAPTA concentration (150µM) needed to restore granule cell excitability in CR−/− cells.
eBased on numerical simulations of buffered Ca2+ diffusion near a single Ca2+ channel or a large cluster of Ca2+ channels (Saftenku, 2012).
the overall structure of hexa-EF-hand proteins might be rather
similar.
REGULATION OF CALRETININ EXPRESSION
Still relatively little is known on the mechanisms of regulation
of CR expression in various tissues; altered CR expression levels
have been reported as the consequence of experimental manipu-
lations or are associated with certain diseases in humans and/or
animal models of these diseases [for more details, see Schwaller,
2009, 2010, 2012]. Based on the substantial sequence homology
in the promoter region including the TATA and CAAT boxes of
the human CALB2 and mouse Calb2 gene (Strauss et al., 1997),
it is reasonable to assume that CR expression is regulated in a
similar manner in the two species, although species differences
in CR expression have been reported before. Neuron-specific
“CR-like” expression of a luciferase reporter gene in cortical cul-
tures is achieved in the presence of the mouse Calb2 promoter
region from −115/+54. The 5′ region of this promoter frag-
ment (−115/−71) selectively binds a nuclear protein present
in cerebellar granule cells and contains an “AP2-like” element
(−90/−80 bp; Figure 1). This element is essential for the neuron-
specific reporter expression (Billing-Marczak et al., 2002). The
same “AP2-like” element doesn’t affect transcriptional activity
in human colon carcinoma and mesothelioma cells indicating
that CR expression in neurons and non-neuronal cell types is
differently regulated (Billing-Marczak et al., 2004). In human
colon cancer cells, CR expression is downregulated by butyrate
(Marilley et al., 2001), a substance derived from intestinal fermen-
tation of dietary fibers by bacteria. Butyrate, a known modulator
of histone acetylation, inhibits the cell cycle and leads to entero-
cyte differentiation. Of the several putative butyrate-responsive
elements (BREs) present in the human CALB2 promoter, two ele-
ments embracing the TATA box act as butyrate-sensitive repressor
elements in colon cancer cells, but not in cells of mesothelial ori-
gin (Figure 1; Haner et al., 2010). This supports the notion of cell
type-specific CALB2 regulation. The rat Calb2 promoter region
contains 3 binding motifs for the transcription factor LEF1/TCF
that binds to β-catenin via its N-terminal region (Figure 1);
β-catenin, not directly binding to DNA, contains a strong trans-
activation domain and is highly expressed in thalamic neurons.
Down-regulation of β-catenin by its negative regulator Axin2 sig-
nificantly reduces CR expression in cultured rat thalamic neurons
indicating that β-catenin is a positive regulator of the Calb2 gene
(Wisniewska et al., 2012). In addition, several transcripts exist
from the human CALB2 gene (Schwaller et al., 1995), which are
present in several colon cancer cell lines (Gander et al., 1996)
and in tumor tissue from primary colon tumors (Schwaller et al.,
1998). One splice variant with deletion of exons 8 and 9 results
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FIGURE 1 | (A) Positions of LEF1/TCF motifs (black rectangles) are present
within conserved (human/rat) non-coding regions flanking the transcription
start site (TSS; pos. +1) of the CALB2/Calb2 genes and are depicted either
above or below the axis depending on the strand (modified from Wisniewska
et al., 2012). The consensus sequence recognized by the DNA-binding
domain of LEF1/TCFs is WWCAAAG (W is either A or T). Nucleotide
numbering is shown with respect to the TSS. In the region −90/−80 of the
mouse Calb2 gene, an “AP2-like” element (white box) is responsible for
neuron-specific expression of the transcript (Billing-Marczak et al., 2002).
A bipartite butyrate-responsive element (BRE; checkered boxes) surrounds
the TATA box and the TSS (Haner et al., 2010). The non-coding part of exon 1
is shown as a white box and the coding region including the ATG start codon
as a striped box. (B) Sequence comparison of the rat, mouse and human
Calb2 gene around the TSS. The “AP2-like” region is boxed in yellow. The
TATA box is marked in bold and the BREs 5 and 6 acting as
butyrate-responsive repressors in colon cancer cells are boxed. The most
highly conserved nucleotides in the BREs (consensus sequence:
GCGGGCTCCA) are shown in green, the less conserved ones in red and the
nucleotides not conforming to the consensus sequence are shown in black.
The TSS (+1) is boxed in green. The start codon ATG is marked in blue.
in a truncated protein named CR-22k of 192 amino acids, which
is expressed in certain tumors (Schwaller et al., 1998); the other
transcript (deletion of exon 8) is currently known to exist only at
the level of mRNA (Schwaller et al., 1995) and might have a func-
tion as an RNA molecule, possibly as a target for micro (mi)RNA
or acting as a long non-coding (lnc) RNA.
THE IDENTIFICATION OF CALRETININ-INTERACTING
TARGETS SUPPORTS CR’S ROLE AS A CA2+ SENSOR
The finding that purified CR undergoes significant Ca2+-
dependent conformational changes in vitro (Kuznicki et al.,
1995; Schwaller et al., 1997), together with the observation
that CR immunoreactivity in chick brainstem auditory neu-
rons changes from diffuse cytosolic staining to intense localized
staining beneath the plasma membrane, which occurs together
with the onset of spontaneous activity (Hack et al., 2000), sug-
gested already in the late 90’s that CR might have additional
Ca2+-sensor functions (Billing-Marczak and Kuznicki, 1995).
Furthermore, CR was shown to be present in membrane fractions
of rat cerebellum (Winsky and Kuznicki, 1995) and to bind to
cytoskeletal elements in WiDr colon cancer cells (Marilley and
Schwaller, 2000). In support of the presence of CR targets, CR
translocates from the cytosol to the nucleus in a vitamin D3-
dependant and/or butyrate-dependent way in colon cancer cells
in vitro, also indicating that CR might have nuclear interaction
partners (Schwaller and Herrmann, 1997). Recently, in two stud-
ies CR targets were identified (Christel et al., 2012; Dong et al.,
2012) and moreover, the interacting domain of CR that leads to
a decreased Ca2+-dependent mobility of CR in cerebellar gran-
ule cells was identified (Arendt et al., 2013). A yeast-two-hybrid
screen with CR as bait, identified a consensus, strongly basic
peptide sequence H(R/K)HRRR(E/D) as a putative CR-binding
(CRB) motif (Christel et al., 2012). This motif is present in mul-
tiple copies (CRB1-5) in the cytoplasmic linker region between
domains II and III of the channel-forming alpha 1 subunit of
the high-voltage activated Ca2+ channel CaV2.1 (P/Q type). This
channel is regulated in a dual fashion by Ca2+ ions, showing
both, Ca2+-dependent inactivation (CDI) and Ca2+-dependent
facilitation (CDF); both mechanisms influence synaptic plastic-
ity in the nervous system. In cells expressing CaV2.1 in vitro,
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co-expression of CR inhibits CDI and enhances CDF via a direct
interaction with the α12.1 subunit. The channel subunit α12.1
co-immunoprecipitates with CR antibodies using either extracts
from HEK293T cells transfected with CR and CaV2.1 or mouse
cerebellar extracts. In mouse cerebellum, both CR and CaV2.1
are strongly expressed in granule cells and the absence of CR in
CR−/− mice causes impairment in motor control (Schiffmann
et al., 1999). This impairment is essentially caused by CR’s absence
in granule cells, since the motor phenotype can be rescued by
selective re-expression of CR in granule cells (Bearzatto et al.,
2006). Thus, the direct modulation of CaV2.1 by CR affects intra-
cellular Ca2+ signaling and probably also neuronal excitability
via a mechanism that is different from CR’s previously proven
Ca2+ buffering function as discussed in Section IV. The inter-
action between CR and interacting partners likely including
CaV2.1 was studied in granule cells by fluorescence recovery after
photobleaching (FRAP). The diffusion of fluorescence-labeled
CR molecules is much slower than the one of freely diffusible
molecules (fluorescein dextrans) of comparable size (Arendt et al.,
2013). Moreover, during a burst of action potentials (APs) that
leads to an increase in dendritic [Ca2+]i, CR’s mobility is further
decreased, indicative of Ca2+-dependent interactions. Addition of
a peptide consisting of EF-hand 5 of CR to granule cells, consider-
ably increases CR’s mobility implicating that the CR interactions
occur mainly via the region of EF-hand 5, the Ca2+-binding site
with very low affinity. Estimations on the density (concentra-
tion) of CaV2.1 channels and CR in granule cells indicate that
channel numbers are too low to account for the strong effect
on CR’s mobility implicating additional, yet unidentified CR-
binding partners in these neurons. A binding partner interacting
with CR was found to be huntingtin (Htt), identified by tan-
dem affinity purification (Dong et al., 2012). Binding to CR is
even stronger with a mutant form of Htt characterized by a
polyglutamine (polyQ) region that is typical for Huntington’s dis-
ease (HD). In neuronal cultures, CR colocalizes with Htt and a
CR/Htt complex can be isolated by co-immunoprecipitation. In
CR-overexpressing HEK293 cells, levels of phosphorylated AKT
(p-AKT) are increased. At the functional level, CR overexpression
reduces mHtt-related H2O2 cytotoxicity in various HD in vitro
models. This might be directly linked to CR’s capacity to decrease
[Ca2+]i in these cells and/or to indirectly increase levels of p-
AKT considered as a pro-survival signal. On the other hand, CR
down-regulation by shRNA enhances mHtt-mediated neuronal
cell death. Based on their findings, the authors conclude that “CR
may be a potential therapeutic target for treatment of HD.” A link
between CR and p-AKT was reported before; increased expres-
sion levels of CR strongly correlate with increased resistance to
asbestos cytotoxicity in immortalized Met-5A mesothelial cells
(Henzi et al., 2009). This protective effect is abrogated in the
presence of phosphatidylinositol 3-kinase (PI3K) inhibitors, in
support of the above findings that increased PI3K/AKT signal-
ing (increased p-AKT) caused by CR up-regulation favors cell
survival. Thus, in the case of CR-expressing mesothelial and
mesothelioma cells, CR or more precisely its down-regulation,
might be viewed as a potential new target/strategy for malignant
mesothelioma therapy (Blum and Schwaller, 2013).
THE EFFECT OF CALRETININ ON INTRACELLULAR CA2+
SIGNALING
The particular Ca2+-binding properties of CR together with its
mobility differently affect intracellular Ca2+ signals, however only
to a measurable extent, if present at a sufficiently high concentra-
tion, typically in the range of tens of μM in neurons. Generally,
lower CR concentrations (≈1μM) don’t affect Ca2+ signals and
e.g., don’t protect PC12 cells against Ca2+ overload induced
by ionophore treatment or trophic factor deprivation (Kuznicki
et al., 1996). Effects of CR on Ca2+ signals are often deduced
from comparing signals in neurons from WT and CR−/− mice
(Schmidt et al., 2013) or when overexpressing or down-regulating
CR in cell culturemodels (Billing-Marczak et al., 1999; D’Orlando
et al., 2001; Pecze et al., 2013). CR’s particular properties, i.e., its
low Ca2+ occupancy at resting [Ca2+]i together with the high co-
operativity resulting in non-linear binding properties in a setting
in which neurotransmitter release depends supralinearly on Ca2+
(e.g., in parallel-fiber (PF) terminals onto Purkinje cells) result
in considerable nanodomain Ca2+-buffering by CR. As a conse-
quence, a minor increase in the amplitude of AP-evoked Ca2+
signals in CR−/− PF boutons results in a considerably higher
release probability (Schmidt et al., 2013). CR-deficient cerebellar
granule cells are characterized by faster APs and, when electrically
stimulated to generate repetitive spike discharges, show enhanced
frequency increase with injected currents, i.e., increased excitabil-
ity (Gall et al., 2003). The excitability can be reverted to the
situation seen in WT cells, by loading the cells with the fast buffer
BAPTA (150μM) strongly indicating that the “fast” Ca2+ buffer-
ing function of CR is most likely responsible for limiting granule
cell excitability. From these experiments it was also deduced that
the CR concentration in these neurons is in the order of 40μM,
based on CR’s 4 high-affinity Ca2+-binding sites; this estima-
tion is in line with modeling studies on CR function (Roussel
et al., 2006). However, other models taking into account CR’s
cooperativity of Ca2+ binding resulting in a delayed equilibra-
tion with Ca2+ predict the concentration of CR to be even higher,
in the order of 0.7–1.2mM (Saftenku, 2012), a value estimated
to be present in frog saccular hair cells (Edmonds et al., 2000).
However, in this model the modulation of the main voltage-
activated Ca2+ channel in granule cells, CaV2.1, by CR (Christel
et al., 2012) was not taken into account. Thus, the precise concen-
tration of CR in granule cells has to be determined yet, possibly
by a in situ calibration method as previously used for the deter-
mination of the concentration of CB (≈40μM) in hippocampal
granule cells (Muller et al., 2005) or of PV in DG basket cells
(11.9 ± 1.6μM) or in cerebellar basket cells (563 ± 66μM)
(Eggermann and Jonas, 2012). The particular biophysical prop-
erties of CR also acting as a slow-onset Ca2+ buffer are best
appreciated from studies inXenopus oocytes (Dargan et al., 2004).
Photo-release of inositol 1,4,5 triphosphate (IP3) evokes Ca2+ sig-
nals that are differently modulated by endogenous or synthetic
Ca2+ buffers (Dargan and Parker, 2003). In the presence of slow
buffers such as PV or EGTA, global Ca2+ signals are fragmented
into local Ca2+ puffs, resulting from Ca2+ release from discrete
clusters of IP3 receptors, while low concentrations of fast buffers
(CB, BAPTA) decrease the amplitude of Ca2+ signals and favor
Frontiers in Neuroanatomy www.frontiersin.org February 2014 | Volume 8 | Article 3 | 4
Schwaller Multifunctional calretinin
“globalization” of spatially uniform Ca2+ signals, in particular, at
high [IP3]. Interestingly, puffs are observed in the presence of CR
at low stimulation intensities, i.e., at low [IP3], an effect never
occurring in the presence of CB or BAPTA. Thus, under condi-
tions of small elevations in [Ca2+]i from resting Ca2+ levels, CR
has properties of a slow Ca2+ buffer such as PV or EGTA.
CALRETININ EXPRESSION IS LINKED TO NEURONAL
DEVELOPMENT
The detailed analyses of temporal and spatial expression of CR
in the brain is the major focus of this Frontiers series, has been
summarized in several papers and reviews Arai et al. (1991);
Jacobowitz and Winsky (1991); Hof et al. (1999); Barinka and
Druga (2010) and is thus not covered in this mini-review. Recent
findings on CR expression (often transient) and neurogenesis
are briefly summarized. Olfactory receptor neurons are generated
throughout lifetime and are characterized by a short period of CR
expression just before these neurons are fully mature (Wei et al.,
2013), yet the functional significance is currently unknown. Also
mouse adult hippocampal neurogenesis, more precisely, the early
postmitotic stage of dentate gyrus (DG) granule cell development
is characterized by transient CR expression (Brandt et al., 2003).
This stage coincides with onset of differentiation and absence of
CR in the immature early postmitotic granule cells of CR−/− mice
(systematic name: Calb2tm1Map) “causes an early loss in prolif-
erative capacity of the subgranular zone that is maintained into
adult age, when it has a further impact on the migration/survival
of newborn granule cells” (Todkar et al., 2012). Interestingly,
when in WT mice newborn cells are functionally integrated in
the DG granule cell network, CR expression stops and is changed
to CB, the typical marker for adult DG granule cells. The func-
tional consequences of this swap from CR to CB expression for
granule cell physiology are currently unknown, as well as the
mechanisms that lead to such a change. Nonetheless, it indicates
Ca2+-binding protein-specific functions that cannot be shared
and/or substituted even by apparently very similar proteins such
as CB and CR.
WHAT IS THE PHYSIOLOGICAL ROLE OF CALRETININ?
As was previously reported for CB (Schmidt, 2012), CR certainly
has more than one function, depending on various parame-
ters including cell type (neurons vs. non-excitable cells including
tumor cells), stages of development (adult vs. developmental
stages) and probably also different neuronal subtypes. For some
proposed roles of CR, e.g., a role in neuroprotection, the pro-
portion of reports, mostly obtained in correlative studies, in
favor or against such a role is almost 50:50 [for more details,
see (Schwaller, 2009, 2010)], clearly necessitating more studies
directly addressing this putative function of CR. Here, just the
most important results obtained in CR−/− mice are summa-
rized. The decreased LTP in the DG is thought to be the result
of an increased excitatory drive from CR-depleted mossy cells
onto hilar interneurons (Schurmans et al., 1997). Most findings
on the function of CR are derived from studies in the cerebellum,
where CR is expressed in cerebellar granule cells. Their increased
excitability in the absence of CR (Gall et al., 2003) is linked to
the altered firing properties (Cheron et al., 2000) and likely Ca2+
homeostasis of Purkinje cells and the emergence of cerebellar
160-Hz oscillations (Cheron et al., 2004) that result in impair-
ment in motor coordination (Schiffmann et al., 1999), for more
details, see Schwaller (2009). Thus, CR expression in granule cells
appears necessary for correct computation that is crucial for the
coding and storage of information in the cerebellum. Of note,
there is currently no data available on CR’s function in cortical
interneurons, e.g., derived from CR−/− mice. I am also not aware
that anybody has attempted to manipulate CR expression levels
of cortical interneurons, e.g., by shRNA and to investigate the
functional consequences of CR down-regulation.
In CR-expressingmesothelial cells, CR down-regulation causes
a G1 block and in mesothelioma-derived cells leads to apoptosis
via strong activation of the intrinsic caspase 9-dependent pathway
(Blum and Schwaller, 2013). A rather similar effect is also seen
in CR-expressing colon cancer cells (Gander et al., 1996) indicat-
ing a role for CR in cell cycle regulation, proliferation, possibly
differentiation and cell death. These findings are in line with tran-
sient CR expression during development, whether in the nervous
system or in other tissues including mesenchymal tissue (Gangji
et al., 1994). In summary, we have just started to unravel the
likely many functions of CR in different settings and there are still
plenty of interesting aspects on CR’s function(s) to be discovered.
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